Legal
No specific prohibition or special access rule has been identified for the listed object and activity in the materials reviewed. General laws can still apply.
Country-by-country reference
Global Legal Map
A careful way to compare how jurisdictions may classify raw iboga, ibogaine, related compounds, extracts, research activity, and clinical administration.
Start with the object
A map for distinctions, not shortcuts
“Ibogaine legal” can compress several separate legal questions into one phrase. A rule concerning a plant material may not address a purified alkaloid; a restriction on possession may not describe a licensed research pathway; a medical rule may concern administration rather than supply.
This page uses the same country-by-country lens as the main legal-status overview: identify the object, identify the activity, and preserve uncertainty where the available legal text does not settle the question.
The terms “ibogaine” and “noribogaine” refer to distinct compounds, while “iboga” may describe plant material associated with Tabernanthe iboga. Those distinctions matter when a statute, schedule, or government notice uses only one of those names.
Status legend
The working taxonomy
Categories describe the available legal pathway or restriction. They do not certify safety, endorse conduct, or replace local legal advice.
Prescription / medical access
Access is described within a medical, prescription, authorization, or regulated-care framework rather than as unrestricted availability.
Research-only
Possession, supply, or administration may be limited to approved research, institutional permissions, or other formally controlled activity.
Unregulated
No ibogaine-specific scheduling or control has been located in the reviewed sources. This is not a conclusion about all import, medicine, customs, or consumer laws.
De facto tolerated
Reported practice may appear less restrictive than the apparent legal framework. The underlying rule may still prohibit or control the activity.
Illegal / scheduled
The listed object is named or captured by a controlled-substance schedule, prohibition, or comparable restriction in the source material reviewed.
Traditional use
Traditional or cultural practice may be recognized, described, or tolerated while separate rules continue to apply to extraction, trade, export, or clinical administration.
Country notes
One jurisdiction can contain several answers
A useful country note separates raw iboga, ibogaine, noribogaine, extracts, and clinical administration. It also distinguishes domestic possession from importation, exportation, manufacture, research, and professional practice.
Where international drug-control context is relevant, the map notes it without treating an international framework as a substitute for national law. The UN Single Convention resource is a useful starting point for understanding why domestic schedules can follow different legal mechanisms and naming conventions.
“A country label is a prompt to inspect the underlying rule—not a guarantee about every material, activity, or local authority.”
For longer entries, the country-specific notes preserve that granularity rather than flattening it into a single yes-or-no answer.
Downloadable reference
Country table: how to read the fields
The table is structured for comparison rather than a definitive legal determination. “Not established” means the reviewed materials do not support a reliable classification for that field.
| Country | Raw iboga | Ibogaine | Noribogaine | Extracts | Clinical administration | Reading note |
|---|---|---|---|---|---|---|
| United States | Not established | Illegal / scheduled | Not established | Not established | Not established | Confirm the current federal record and applicable state rules. |
| Gabon | Traditional use | Not established | Not established | Not established | Not established | Traditional practice and separate commercial or clinical rules should not be conflated. |
| Canada | Not established | Not established | Not established | Not established | Not established | Review current federal and provincial requirements before drawing conclusions. |
| Netherlands | Not established | Not established | Not established | Not established | Not established | Separate national rules from local practice and from claims about service availability. |
Provenance
Method before certainty
This reference prioritizes primary legal text, official government notices, regulatory records, and official international materials where they are available. Secondary sources can help locate a law or identify a terminology issue, but they are not treated as a replacement for the source itself.
For the United States, a scheduled-substance question should be checked against the DEA controlled-substances schedules and then compared with the rule actually relevant to the activity and jurisdiction.
Legal classifications can change through schedules, regulations, court decisions, administrative guidance, licensing conditions, and local enforcement. This map records uncertainty openly; it does not turn incomplete evidence into legal advice. For an explanation of the project’s information standards, see the approach behind Ibogaine Legal Map.
Common reading questions
Use the map with care
A country-by-country overview is most useful when it makes limits visible. The questions below explain how the categories should be read.
Does a legal status apply to every form of ibogaine-related material?
No. A country may treat raw iboga, ibogaine, extracts, noribogaine, research possession, importation, and clinical administration differently. The map separates these objects where the available source material supports that distinction.
Why can a country be marked uncertain or de facto tolerated?
Legal text may be incomplete, difficult to access, limited to a particular substance name, or different from reported enforcement practice. Uncertainty is shown rather than converted into a definitive legal conclusion.
Can this map confirm whether an activity is lawful today?
No. This is an informational reference, not legal advice. Laws, regulations, licensing conditions, and enforcement practices can change. Consult current primary legal materials and qualified local advice for decisions.